StoneCrest Wealth Management »

Miragen Therapeutics shares owned by StoneCrest Wealth Management

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by StoneCrest Wealth Management from 13F filings

Historical chart of StoneCrest Wealth Management investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by StoneCrest Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by StoneCrest Wealth Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $539k 25k 21.58
2025-06-30 $351k 25k 13.98
2025-03-31 $347k 26k 13.48
2024-12-31 $496k 26k 19.17
2024-09-30 $628k 28k 22.75
2024-06-30 $358k 28k 13.01
2024-03-31 $485k 28k 17.51
2023-12-31 $605k 28k 21.78

More positions owned by StoneCrest Wealth Management

Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
NVIDIA Corporation (NVDA)
Invesco Exch Traded Fd Tr Ii S&p Intl Momnt (IDMO)
Invesco Exch Traded Fd Tr Ii S&p 500 Momntm (SPMO)
Spdr Series Trust Portfolio S&p500 (SPLG)
Putnam Etf Trust Focused Lar Cap (PVAL)
Bny Mellon Etf Trust Ii Dynamic Value (BKDV)
First Tr Exchange Traded Risng Divd Achiv (RDVY)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Amazon (AMZN)
Vaneck Etf Trust Semiconductr Etf (SMH)
Alphabet Cap Stk Cl A (GOOGL)
First Tr Exchange Traded Nasdaq Cyb Etf (CIBR)
Global X Fds Defense Tech Etf (SHLD)

View all positions for StoneCrest Wealth Management

Top funds holding Miragen Therapeutics

FMR
BlackRock
Deep Track Capital
Kynam Capital Management
Vanguard Group
VR Adviser
Fairmount Funds Management
Commodore Capital
Tang Capital Management
Paradigm Biocapital Advisors
State Street Corporation
Novo A/S
Maverick Capital
Eversept Partners
Alliancebernstein

View all funds holding Miragen Therapeutics